Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

182.12 -0.17 (-0.09%)
Official Closing Price Updated: 4:10 PM EDT, Jun 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
More than four in 10 people in a recent survey knew of someone with long Covid. 
Via Investor's Business Daily
Tigecycline Market Development Factors 2022-2029 Pfizer, Hisun Pharma, Hansoh Pharma, HICIN Pharma, Amgen
Global Tigecycline Market Research 2022-2031 published by Calibre Research studies the current situation, Tigecycline market size, share, trends, regional growth and the latest technologies utilized by... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
This Biotech Company Says That It's Looking To Deliver A Breakthrough In Psychiatric Medicine — What's The Scoop?
Pasithea Therapeutics Corp. (NASDAQ: KTTA) is a biotech company with a goal of investigating novel drug treatments to provide more effective relief to the estimated 792 million people around the world... 
Via Benzinga
Could This Company's Gastrointestinal Drug Be A Powerful Pill For People And Animals With Chronic, Debilitating Diarrhea?
San Francisco-based Jaguar Health, Inc. (NASDAQ: JAGX), a commercial-stage pharmaceuticals company, says it is focused on developing novel, plant-based, non-opioid and sustainably derived prescription... 
Via Benzinga
Why Did HC Wainwright Downgrade Addex Therapeutics
 
Via Benzinga
Legend Biotech Shares Move Higher After Bullish BMO Pitch
 
Via Benzinga
With Zero Revenue, Laekna Plays Chicken-And-Egg Game With Investors
Key Takeaways: Laekna is seeking a Hong Kong IPO to raise funds to accelerate the commercialize two core products licensed from Novartis The company currently is not generating... 
Via Benzinga
7 Large-Cap Stocks to Buy After the Next Big Correction
Large-cap stocks to buy with the broad market correction. Stocks to buy and hold for the long-term for dividends and stock upside. 
Via InvestorPlace
Global Medical Box Market 2022: Latest Global Research Report and Analysis by Regions 2029 : 3M, Johnson & Johnson, Acme United, ZEE, Certified Safety
The research study on the global Medical Box market is a blend of informative statistics, quantitative & quantitative evaluation that has been offered by industry specialists, and key participants... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Here's How Much You Would Have Made Owning Johnson & Johnson Stock In The Last 15 Years
Johnson & Johnson (NYSE:JNJ) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 7.34%. Currently, Johnson & Johnson has a market... 
Via Benzinga
Addex Stops Parkinson's-Associated Dyskinesia Trial - Read Here Why
 
Via Benzinga
7 Retirement Stocks to Buy After Age 30
Inflation, interest rate hikes, recessions. There's a lot to worry about right now. But these seven retirement stocks can overcome these obstacles. 
Via InvestorPlace
Global Radioligand Therapy Market | Key Players are Johnson & Johnson Services, Inc., Pfizer Inc., Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Amneal Pharmaceuticals LLC, Novartis International AG and many more.
Global Radioligand Therapy Market | Key Players are Johnson & Johnson Services, Inc., Pfizer Inc., Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Amneal Pharmaceuticals LLC, Novartis... 
Via iCrowdNewswire
Check Out What Whales Are Doing With JNJ
A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 20 strange trades. 
Via Benzinga
Bear Market 2022: Is There Anything Left to Invest In?
Bear markets often present the best investment opportunities. Consider the following strategies to profit in this 2022 bear market. 
Via InvestorPlace
Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
With an economic hurricane on the horizon, investors are searching for alternative investment paths and profitable places to invest in. 
Via InvestorPlace
7 Stocks to Buy If You Have $1,000 to Invest
In a tough market, like we're currently experiencing, the best stocks to buy are those that have sound balance sheets and good prospects. 
Via InvestorPlace
Looking At Johnson & Johnson's Recent Whale Trades
Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Johnson & Johnson Urges FDA To Take Interim Steps As It Continues To Review CBD
The FDA's Science Board has once again reviewed the idea of incorporating cannabinoids into dietary supplements. 
Via Benzinga
3 Super-Safe Dividend Stocks to Buy
Investors seeking dividend income during times of market instability should consider buying these blue-chip companies. 
Via InvestorPlace
Mistaken Identity? Drink Maker Celsius Falls 10% On Monday
“What’s in a name? That which we call a rose by any other name would smell just as sweet.” A beverage company might be wishing it didn’t share a name with a cryptocurrency platform after being... 
Via Benzinga
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
Here's why its protein-based shot could struggle in the U.S. 
Via Investor's Business Daily
5 Biotech Stocks To Watch During The Week Of June 13
Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves. Here's a... 
Via Benzinga
7 Great ETFs to Buy Now for Momentum in Q2
These seven ETFs to buy are among the best funds. YPS, BITQ, FMET, QQMG, DVY, XSD, and VHT can make excellent investments. 
Via InvestorPlace
Relief May Soon Be On The Way For Diabetes Sufferers Weary Of Constant Pin Pricks, According To This Company
Last year was the 100th anniversary of the discovery of insulin, which was instrumental in improving people's lives around the world. 
Via Benzinga
What Are Whales Doing With Johnson & Johnson
Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
NVAX Stock Price Predictions: Where Will Novavax Go From Here?
NVAX stock price predictions are in the spotlight after its vaccine got an unanimous recommendation from the FDA's advisory panel yesterday. 
Via InvestorPlace
Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments
SOURCE: Johnson & Johnson 
Via 3BL Media
CNBC's Final Trades: Starbucks, Johnson & Johnson, Union Pacific And This Way To Gain Exposure To Gold
On CNBC’s “Halftime Report Final Trades,” Stephanie Link of Hightower said Starbucks Corporation’s (NASDAQ: SBUX) U.S. 
Via Benzinga
COVID-19 Vaccine Patent Waiver Expected Soon, Says WTO Head: Reuters
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.